Handok
HANDOK Inc. operates as a pharmaceutical company. The company provides prescription and OTC drugs; medical devices, such as blood pressure monitors, cholesterol monitoring systems, insulin pumps, self-monitoring system of blood glucose, and blood glucose monitoring system; in vitro diagnostic medical devices; as well as life science products. It also offers healthcare products comprising food sup… Read more
Handok (002390) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.042x
Based on the latest financial reports, Handok (002390) has a cash flow conversion efficiency ratio of 0.042x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩11.37 Billion) by net assets (₩267.88 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Handok - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Handok's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Handok Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Handok ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lavras Gold Corp.
OTCQX:LGCFF
|
-0.018x |
|
CoTec Holdings Corp.
V:CTH
|
-0.019x |
|
JASTECH Ltd
KQ:090470
|
-0.043x |
|
Kronos Bio Inc
NASDAQ:KRON
|
-0.161x |
|
Los Andes Copper Ltd
OTCQX:LSANF
|
-0.003x |
|
Yangarra Resources Ltd
PINK:YGRAF
|
0.024x |
|
Taokaenoi Food & Marketing Public Company Limited
BK:TKN
|
0.148x |
|
D0X
F:D0X
|
-0.041x |
Annual Cash Flow Conversion Efficiency for Handok (2011–2024)
The table below shows the annual cash flow conversion efficiency of Handok from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩289.06 Billion | ₩-2.79 Billion | -0.010x | -109.13% |
| 2023-12-31 | ₩340.63 Billion | ₩35.98 Billion | 0.106x | +32.15% |
| 2022-12-31 | ₩381.86 Billion | ₩30.52 Billion | 0.080x | -17.56% |
| 2021-12-31 | ₩384.00 Billion | ₩37.23 Billion | 0.097x | +52.09% |
| 2020-12-31 | ₩381.85 Billion | ₩24.34 Billion | 0.064x | +149.23% |
| 2019-12-31 | ₩343.99 Billion | ₩8.80 Billion | 0.026x | -72.79% |
| 2018-12-31 | ₩313.38 Billion | ₩29.46 Billion | 0.094x | +302.39% |
| 2017-12-31 | ₩290.71 Billion | ₩6.79 Billion | 0.023x | +179.47% |
| 2016-12-31 | ₩289.25 Billion | ₩-8.50 Billion | -0.029x | -160.97% |
| 2015-12-31 | ₩303.71 Billion | ₩14.64 Billion | 0.048x | -59.42% |
| 2014-12-31 | ₩307.77 Billion | ₩36.56 Billion | 0.119x | +276.75% |
| 2013-12-31 | ₩294.28 Billion | ₩9.28 Billion | 0.032x | -26.21% |
| 2012-12-31 | ₩287.25 Billion | ₩12.28 Billion | 0.043x | -75.26% |
| 2011-12-31 | ₩278.34 Billion | ₩48.08 Billion | 0.173x | -- |